Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Interest Expenses (2020 - 2025)

Journey Medical (DERM) has disclosed Interest Expenses for 6 consecutive years, with $937000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses rose 23.61% year-over-year to $937000.0, compared with a TTM value of $3.6 million through Sep 2025, up 89.96%, and an annual FY2024 reading of $2.7 million, up 59.01% over the prior year.
  • Interest Expenses was $937000.0 for Q3 2025 at Journey Medical, roughly flat from $937000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $4.1 million in Q4 2021 and bottomed at $24000.0 in Q4 2023.
  • Average Interest Expenses over 5 years is $840947.4, with a median of $650000.0 recorded in 2023.
  • The sharpest move saw Interest Expenses tumbled 96.11% in 2023, then surged 3362.5% in 2024.
  • Year by year, Interest Expenses stood at $4.1 million in 2021, then plummeted by 84.94% to $617000.0 in 2022, then crashed by 96.11% to $24000.0 in 2023, then soared by 3362.5% to $831000.0 in 2024, then grew by 12.76% to $937000.0 in 2025.
  • Business Quant data shows Interest Expenses for DERM at $937000.0 in Q3 2025, $937000.0 in Q2 2025, and $891000.0 in Q1 2025.